Israel Englander Passage Bio, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Passage Bio, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 163,859 shares of PASG stock, worth $108,146. This represents 0.0% of its overall portfolio holdings.

Number of Shares

163,859

Previous 750,926 78.18%

Holding current value

$108,146

Previous $593,000 80.78%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.64 - $1.0 $375,722 - $587,067	-587,067 Reduced 78.18%	163,859 $114,000
Q2 2024 Aug 14, 2024	SELL	$0.79 - $1.58 $90,702 - $181,404	-114,813 Reduced 13.26%	750,926 $593,000
Q1 2024 May 15, 2024	BUY	$0.86 - $1.73 $66,705 - $134,185	77,564 Added 9.84%	865,739 $1.17 Million
Q4 2023 Feb 14, 2024	BUY	$0.6 - $1.01 $348,427 - $586,519	580,712 Added 279.91%	788,175 $796,000
Q2 2023 Aug 14, 2023	SELL	$0.82 - $1.19 $74,314 - $107,846	-90,627 Reduced 30.4%	207,463 $195,000
Q1 2023 May 15, 2023	SELL	$0.96 - $1.88 $183,754 - $359,852	-191,411 Reduced 39.1%	298,090 $285,000
Q4 2022 Feb 14, 2023	SELL	$1.06 - $1.48 $86,645 - $120,976	-81,741 Reduced 14.31%	489,501 $676,000
Q3 2022 Nov 14, 2022	BUY	$1.22 - $2.48 $235,323 - $478,362	192,888 Added 50.98%	571,242 $714,000
Q2 2022 Aug 15, 2022	BUY	$1.63 - $3.46 $340,404 - $722,576	208,837 Added 123.2%	378,354 $893,000
Q1 2022 May 16, 2022	SELL	$2.66 - $6.49 $93,464 - $228,039	-35,137 Reduced 17.17%	169,517 $526,000
Q4 2021 Feb 14, 2022	SELL	$6.24 - $10.2 $870,629 - $1.42 Million	-139,524 Reduced 40.54%	204,654 $1.3 Million
Q3 2021 Nov 15, 2021	BUY	$9.73 - $15.52 $1.45 Million - $2.31 Million	148,982 Added 76.32%	344,178 $3.43 Million
Q2 2021 Aug 16, 2021	BUY	$12.44 - $19.45 $2.43 Million - $3.8 Million	195,196 New	195,196 $2.58 Million
Q1 2021 May 17, 2021	SELL	$16.24 - $29.83 $1.75 Million - $3.21 Million	-107,579 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$14.28 - $29.73 $720,997 - $1.5 Million	50,490 Added 88.44%	107,579 $2.75 Million
Q3 2020 Nov 16, 2020	BUY	$12.39 - $26.15 $707,332 - $1.49 Million	57,089 New	57,089 $748,000
Q2 2020 Aug 14, 2020	SELL	$14.59 - $36.07 $2.39 Million - $5.91 Million	-163,853 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$8.86 - $22.2 $1.45 Million - $3.64 Million	163,853 New	163,853 $2.58 Million

Others Institutions Holding PASG

# of Institutions

Shares Held

38.7M

Call Options Held

7.7K

Put Options Held

View Full List

About Passage BIO, Inc.

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $35.9M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

More about PASG

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account